Brainstorm Cell Therapeutics reported $-6858000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Biogen BIIB:US USD 821M 53.8M
Brainstorm Cell Therapeutics BCLI:US USD -6858000 183K
Cytokinetics CYTK:US USD -142310000 122.49M
Halozyme Therapeutics HALO:US USD 73.71M 21.78M
Idera Pharmaceuticals IDRA:US USD 9.14M 14.44M
Mesoblast MSB:AU USD -42854000 5.88M